Clinical Trial Update: Evaluation of Mineralized Plasmatic Matrix With and Without Collagen Membrane in Peri-implant Bone Regeneration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mineralized plasmatic matrix with and without collagen membrane for peri-implant bone regeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Loss
• Horizontal Alveolar Bone Defect

Drugs mentioned

• Collagen Membrane (collagen membrane)
• Mineralized Plasmatic Matrix

Snippet

Sponsor: Alexandria University | Conditions: Horizontal Alveolar Bone Defect, Alveolar Bone Loss | Phase 2 | Status: COMPLETED